4.0 Article

miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway

Journal

BMC CELL BIOLOGY
Volume 18, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/s12860-016-0123-7

Keywords

miR-27b; Fibroblast activation; TGF beta; Idiopathic pulmonary fibrosis

Categories

Funding

  1. National Heart, Lung and Blood Institute [R01 HL116876]
  2. National Institute of General Medical Sciences [P20GM103648]
  3. Oklahoma Center for Adult Stem Cell Research
  4. Guangdong Natural Science Foundation [2014A030313370]
  5. Jinan University Innovation Foundation [21615420]

Ask authors/readers for more resources

Background: MicroRNAs are a group of small RNAs that regulate gene expression at the posttranscriptional level. They regulate almost every aspect of cellular processes. In this study, we investigated whether miR-27b regulates pulmonary fibroblast activation. Results: We found that miR-27b was down-regulated in fibrotic lungs and fibroblasts from an experimental mouse model of pulmonary fibrosis. The overexpression of miR-27b with a lentiviral vector inhibited TGF beta 1-stimulated mRNA expression of collagens (COL1A1, COL3A1, and COL4A1) and alpha-smooth muscle actin, and protein expression of Col3A1 and alpha-smooth muscle actin in LL29 human pulmonary fibroblasts. miR-27b also reduced contractile activity of LL29. TGF beta receptor 1 and SMAD2 were identified as the targets of miR-27b by 3'-untranslated region luciferase reporter and western blotting assays. Conclusions: Our results suggest that miR-27b is an anti-fibrotic microRNA that inhibits fibroblast activation by targeting TGF receptor 1 and SMAD2. This discovery may provide new targets for therapeutic interventions of idiopathic pulmonary fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available